AR018867A1 - Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche - Google Patents

Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche

Info

Publication number
AR018867A1
AR018867A1 ARP990102846A ARP990102846A AR018867A1 AR 018867 A1 AR018867 A1 AR 018867A1 AR P990102846 A ARP990102846 A AR P990102846A AR P990102846 A ARP990102846 A AR P990102846A AR 018867 A1 AR018867 A1 AR 018867A1
Authority
AR
Argentina
Prior art keywords
composition
case
compositions
compounds
prepare
Prior art date
Application number
ARP990102846A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR018867A1 publication Critical patent/AR018867A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Abstract

Se describen composiciones farmacéuticas de combinacion, uso para la preparacion de estuches y composiciones que comprenden (-)-cis-6-fenil-5-(4-(2-pirrolidin-1-il-exoti)-fenil)-5,6,7,8- tetrahidronaftalen-2-ol, o una de sus sales farmacéuticamente aceptable y hormona paratiroidea, o uno de sus fragmentosbiologicamente activos, usar de dichas composiciones y a estuches que contienen dichas composiciones. Las composiciones son utiles para tratar fragilidadmusculoesquelética, incluyendo osteoporosis, fractura osteroposrotica, masa osea reducida y fragilidad.
ARP990102846A 1998-06-16 1999-06-15 Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche AR018867A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8947998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
AR018867A1 true AR018867A1 (es) 2001-12-12

Family

ID=22217879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102846A AR018867A1 (es) 1998-06-16 1999-06-15 Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche

Country Status (34)

Country Link
US (1) US6132774A (es)
EP (1) EP1094808A1 (es)
JP (1) JP2002518323A (es)
KR (1) KR20010052818A (es)
CN (1) CN1305373A (es)
AP (1) AP9901580A0 (es)
AR (1) AR018867A1 (es)
AU (1) AU3725999A (es)
BG (1) BG105125A (es)
BR (1) BR9911228A (es)
CA (1) CA2335078A1 (es)
CO (1) CO5070584A1 (es)
EA (1) EA200001199A1 (es)
GT (1) GT199900066A (es)
HN (1) HN1999000063A (es)
HR (1) HRP20000858A2 (es)
HU (1) HUP0102759A3 (es)
ID (1) ID26873A (es)
IL (1) IL139588A0 (es)
IS (1) IS5719A (es)
MA (1) MA26649A1 (es)
NO (1) NO20006313D0 (es)
NZ (1) NZ508039A (es)
OA (1) OA11566A (es)
PA (1) PA8471201A1 (es)
PE (1) PE20000644A1 (es)
PL (1) PL344982A1 (es)
SK (1) SK18922000A3 (es)
TN (1) TNSN99119A1 (es)
TR (1) TR200003567T2 (es)
UA (1) UA60367C2 (es)
WO (1) WO1999065482A1 (es)
YU (1) YU75800A (es)
ZA (1) ZA993972B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
AU2005308575A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as HMG Co-A reductase inhibitors for the treatment of lipidemia
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
TW201043595A (en) * 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) * 2018-10-18 2020-04-28 常州大学 孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254595A (en) * 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
UA60367C2 (uk) 2003-10-15
ID26873A (id) 2001-02-15
CN1305373A (zh) 2001-07-25
IS5719A (is) 2000-11-21
EP1094808A1 (en) 2001-05-02
US6132774A (en) 2000-10-17
EA200001199A1 (ru) 2001-04-23
GT199900066A (es) 2000-10-31
BG105125A (en) 2001-11-30
AP9901580A0 (en) 1999-06-30
TNSN99119A1 (fr) 2005-11-10
CO5070584A1 (es) 2001-08-28
ZA993972B (en) 2000-12-15
HRP20000858A2 (en) 2001-10-31
HUP0102759A2 (hu) 2002-03-28
KR20010052818A (ko) 2001-06-25
HN1999000063A (es) 2000-01-12
WO1999065482A1 (en) 1999-12-23
SK18922000A3 (sk) 2001-09-11
NO20006313L (no) 2000-12-12
AU3725999A (en) 2000-01-05
PA8471201A1 (es) 2000-09-29
CA2335078A1 (en) 1999-12-23
HUP0102759A3 (en) 2002-12-28
PE20000644A1 (es) 2000-08-02
NO20006313D0 (no) 2000-12-12
NZ508039A (en) 2003-03-28
IL139588A0 (en) 2002-02-10
OA11566A (en) 2004-05-26
JP2002518323A (ja) 2002-06-25
MA26649A1 (fr) 2004-12-20
YU75800A (sh) 2003-12-31
BR9911228A (pt) 2001-02-13
TR200003567T2 (tr) 2001-06-21
PL344982A1 (en) 2001-11-19

Similar Documents

Publication Publication Date Title
AR018867A1 (es) Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche
GT199800158A (es) Agonistas de prostaglandinas.
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
GT199900022A (es) Compuestos para el tratamiento de la isquemia
AR034898A1 (es) Composicion cristalina que contiene escitalopram
DK0863891T3 (da) (Methylsulfonyl)phenyl-2-(5H)-furanoner som COX2-inhibitorer
AR032136A1 (es) Compuestos espiroheterociclicos utiles como inhibidores reversibles de cisteina-proteasas
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
BR9804437A (pt) Compostos para a osteoporose
CO4910163A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
AR015493A1 (es) DERIVADOS CICLOHEXILOS , COMPOSICIONES FARMACÉUTICAS Y EL USO DE LOS MISMOS PARA LA MANUFACTURA DE UNA COMPOSICIoN uTIL PARA INHIBIR LA ACTIVIDAD IN VITRO DE NEURAMINIDASA Y PARA EL TRATAMIENTO O PROFILAXIS DE LA INFECCIoN DE INFLUENZA Y PARA TRATAIMIENTO, Y UN MÉTODO IN VITRO PARA INHIBIR LA ACTIVI
IS6658A (is) Ný efnasambönd
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
PA8452701A1 (es) Agonistas de prostaglandinas
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
ID18079A (id) Komposisi farmasi yang mengandung bahan pemercepat osteogenesis
ES2067874T3 (es) Derivados de acetamida.
NO983530D0 (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
DE60329329D1 (de) Altend
ECSP003859A (es) Composicion para el tratamiento de tejidos dañados
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
AR018869A1 (es) Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene

Legal Events

Date Code Title Description
FA Abandonment or withdrawal